SNOA has been in the news 750% more than usual
Sep 12, 2024, 2:32 PM
-7.40%
What does SNOA do
Sonoma Pharmaceuticals, headquartered in Boulder, Colorado, develops hypochlorous acid products for various healthcare applications and went public on January 26, 2007. Their product lineup includes Lumacyn, Regenacyn, and MicrocynAH for skin and wound care.
SNOA has been in the news recently: Sonoma Pharmaceuticals, Inc. has partnered with EMC Pharma to co-market new eye care products, Ocucyn and Acuicyn, which will be launched at a conference in October 2024. Meanwhile, Williams-Sonoma, Inc. announced a quarterly cash dividend of $0.57 per share, set to be paid on November 22, 2024, to shareholders recorded by October 18, 2024.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.